What Could be Changed in the 2012 Taiwan ST-Segment Elevation Myocardial Infarction Guideline? - Wikidata - wikimedia - TriplyDB

What Could be Changed in the 2012 Taiwan ST-Segment Elevation Myocardial Infarction Guideline?

What Could be Changed in the 2012 Taiwan ST-Segment Elevation Myocardial Infarction Guideline?

http://www.wikidata.org/entity/Q28468713

about

In-Hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team for STEMI Patients is Associated with Improved Late Clinical Outcomes A Rare Case of Ticagrelor-Induced Profound Isolated Thrombocytopenia.SYNTAX Score of Infarct-Related Artery Other Than the Number of Coronary Balloon Inflations and Deflations as an Independent Predictor of Contrast-Induced Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction.

P2860

Q37131811-E601D64B-72C5-4338-AAF9-2559F17EE077 Q41669674-FD1AC0D8-071F-4A9E-AFDE-8EED17448204 Q42339378-702313FA-208E-492D-849D-1F93043E2464

P2860

What Could be Changed in the 2012 Taiwan ST-Segment Elevation Myocardial Infarction Guideline?

http://www.wikidata.org/entity/Q28468713

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@ast

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@en

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@nl

type

label

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@ast

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@en

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@nl

prefLabel

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@ast

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@en

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@nl

P1433

Q28468713-38C31E3B-6DB3-419C-AC50-EDB9FE76C7DD

P1476

Q28468713-D2E5C6B1-B2C4-4138-9ACA-2C36D8D912CD

P2093

Q28468713-0AA6D7B5-5CD0-4E8B-8A40-F43B9CC7D493

Q28468713-3D967C50-2199-4860-B6BC-A2A6FFC6236E

Q28468713-94CE99D2-8841-4598-9356-F9AD6DD45B1D

Q28468713-D64A9841-150C-473A-980F-EA0FD7CB67DC

P2860

Q28468713-05A89ADC-0A0F-4C55-8D95-B12ACE8AB936

Q28468713-09675409-63D4-4DE3-9E20-6F9C40424183

Q28468713-5F5EC057-2498-428C-8437-72EF8FD80A47

Q28468713-66904BCE-1574-40ED-B7C8-3A96570F43E6

Q28468713-6C0FFE79-61B3-417B-B142-936C69E6B88E

Q28468713-A7464085-F702-420F-A771-A19C6E5EDAE0

Q28468713-B3D938A6-232A-40EE-9C17-A04264B29365

Q28468713-CA3129E9-D33F-4CD6-8F49-8BDE6F4E401E

Q28468713-D00FAFD8-CDC5-46EC-BA55-106D3FF0B012

Q28468713-DA1D58C9-21FD-4899-B787-4F0DDF5A6FB0

P304

Q28468713-79CFAF08-CEEE-47E7-A089-1366B679BFB8

P31

Q28468713-B02254FA-AC00-4F4B-A04A-4C504EFF7709

P407

Q28468713-6FBD05D7-3BD3-42EF-A5CC-F5E8C9D6B158

P433

Q28468713-9C403261-C8DB-43AC-B485-F0E3C534AF07

P478

Q28468713-51FCFAD1-B841-4372-9ACB-715AB22FE233

P577

Q28468713-8DC4A37F-3C6C-492C-AFDE-3D6729730C58

P698

Q28468713-B7BDE710-2EE1-407D-A074-FD0AF8A6DB50

P921

Q28468713-8F79EA86-FDE2-4858-986D-FA8B4CC4B2C3

P932

Q28468713-D53BEB04-6CBD-4210-A461-88764CB5F337

P1433

Acta Cardiologica Sinica

P1476

What Could be Changed in the 2 ...... ocardial Infarction Guideline?

@en

P2093

Feng-You Kuo

http://www.w3.org/2001/XMLSchema#string

I-Chang Hsieh

http://www.w3.org/2001/XMLSchema#string

Kou-Gi Shyu

http://www.w3.org/2001/XMLSchema#string

Yi-Heng Li

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.

Network models for large cities: the European experience.

Improvement in door-to-balloon (D2B) time in acute ST-elevation myocardial infarction through the D2B alliance--experience of 15 primary percutaneous coronary intervention centers in Taiwan.

Benefit of revascularization in non-infarct-related artery in multivessel disease patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Thrombus aspiration during ST-segment elevation myocardial infarction.

Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.

P304

360-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27122812

http://www.w3.org/2001/XMLSchema#string

P921

P932

4834952

http://www.w3.org/2001/XMLSchema#string